Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
Sarepta Therapeutics Inc banner

Sarepta Therapeutics Inc
LSE:0L35

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
LSE:0L35
Watchlist
Price: 21.092 USD 0.06% Market Closed
Market Cap: $171.7B
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for Sarepta Therapeutics Inc (0L35) under the Base Case is 72.999 USD. Compared with the current market price of 21.092 USD, the stock appears Undervalued by 71%.

Based on two methods:
DCF Value
$10.797
Multiples-Based Value
$135.202
DCF Value
$10.797
Multiples-Based Value
$135.202

DCF suggests overvaluation, while multiples suggest undervaluation.

0L35 Intrinsic Value
72.999 USD
Why this value?
Undervaluation 71%
Intrinsic Value
Price $21.092
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $58.4
Get notified when the price drops into your buy zone
Intrinsic Value $73
Margin of Safety 20% $58.4
Current Price $21.09
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
What is Valuation History?
Ask AI Assistant
What other research platforms think about 0L35?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0L35 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sarepta Therapeutics Inc.

Explain Valuation
Alternatives to 0L35

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Sarepta Therapeutics Inc

Wall St
Price Targets

Capital Returns

Competitive Landscape

Ownership

SRPT Insider Trading
Buy and sell transactions by insiders

0L35 News

See Also

Summary
0L35 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0L35 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0L35 stock valuation using valuation multiples.
Wall Street Estimates
0L35 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0L35 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one 0L35 stock?

The intrinsic value for Sarepta Therapeutics Inc (0L35) under the Base Case is 72.999 USD.

Is 0L35 stock undervalued or overvalued?

Compared with the current market price of 21.092 USD, the stock appears Undervalued by 71%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 334,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett